loader
Please Wait
Applying Filters...

Minakem Generic APIs Minakem Generic APIs

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Vebreltinib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Vebreltinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    2D Structure
    1. Also known as: Vebreltinib, 1440964-89-5, Plb-1001, Apl-101, Vebreltinib [usan], Cbi-3103
    Molecular Formula
    C20H15F3N8
    Molecular Weight
    424.4  g/mol
    InChI Key
    QHXLXUIZUCJRKV-UHFFFAOYSA-N
    FDA UNII
    2WZP8A9VFN
    Vebreltinib is an orally bioavailable inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor; HGFR) with potential antineoplastic activity. Upon administration, vebreltinib selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
    2.1.2 InChI
    InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3
    2.1.3 InChI Key
    QHXLXUIZUCJRKV-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F
    2.2 Other Identifiers
    2.2.1 UNII
    2WZP8A9VFN
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Vebreltinib

    2. 1440964-89-5

    3. Plb-1001

    4. Apl-101

    5. Vebreltinib [usan]

    6. Cbi-3103

    7. 2wzp8a9vfn

    8. Cbt-101

    9. 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine

    10. 1,2,4-triazolo(4,3-b)pyridazine, 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6- Fluoro-2-methyl-2h-indazol-5-yl)methyl)-

    11. 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2h-indazol-5- Yl)methyl)-1,2,4-triazolo(4,3-b)pyridazine

    12. Unii-2wzp8a9vfn

    13. Vebreltinib [inn]

    14. Bozitinib (plb-1001)

    15. Vebreltinib [who-dd]

    16. Chembl4650443

    17. Schembl15594471

    18. Gtpl11677

    19. Plb1001

    20. Bdbm107096

    21. Ex-a5644

    22. S6762

    23. Who 11677

    24. Hy-125017

    25. Cs-0088607

    26. Us9695175, 44

    27. A937089

    28. Plb-1001;t-101; Apl-101; Cbi-3103

    29. 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2h-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine

    2.4 Create Date
    2013-12-23
    3 Chemical and Physical Properties
    Molecular Weight 424.4 g/mol
    Molecular Formula C20H15F3N8
    XLogP32.1
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count4
    Exact Mass424.13717700 g/mol
    Monoisotopic Mass424.13717700 g/mol
    Topological Polar Surface Area78.7 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity681
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY